Part one of this two-part webinar series explores how long-read panels are transforming genomic analysis in cancer research.

In this session, we’ll introduce long-read sequencing and examine how it overcomes the limitations of short-read technologies – particularly in resolving complex cancer-associated structural variations, phasing haplotypes for allele-specific expression analysis in tumors and navigating challenging and often rearranged genomic regions in cancer. You’ll gain insights into the added value of long reads in capturing comprehensive genomic information relevant to tumor development and progression. 

We‘ll also highlight the role of hybrid capture technologies in enabling targeted enrichment for both long- and short-read platforms. This approach maximizes sequencing efficiency and data quality while expanding the reach of your analysis.

Join us as we lay the groundwork for understanding the complementary nature of long- and short-read sequencing – setting the stage for deeper, integrated analysis in part two of the series.